Development and characterization of monoclonal antibodies against inhibin α subunit as a potential cancer biomarker

Key Points

• Monoclonal antibodies against the inhibin alpha subunit show promise as cancer biomarkers, aiding early detection.
• The study demonstrates the development of these antibodies through specific immunoassays, supporting diagnostics.
• High specificity and sensitivity of the antibodies were crucial metrics for evaluation in cancer detection applications.
• This work highlights the potential for new diagnostic tools based on inhibin alpha subunit biomarkers in clinical settings.